Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
SEC Accession No. 0001493152-23-036563
Filing Date
2023-10-06
Accepted
2023-10-06 17:26:04
Documents
75

Document Format Files

Seq Description Document Type Size
1 forms-1a.htm   iXBRL S-1/A 3529669
2 ex23-1.htm EX-23.1 3671
3 forms-1_001.jpg GRAPHIC 10816
4 fin_001.jpg GRAPHIC 7745
  Complete submission text file 0001493152-23-036563.txt   13673924

Data Files

Seq Description Document Type Size
5 XBRL SCHEMA FILE ppcb-20230630.xsd EX-101.SCH 80311
6 XBRL CALCULATION FILE ppcb-20230630_cal.xml EX-101.CAL 76355
7 XBRL DEFINITION FILE ppcb-20230630_def.xml EX-101.DEF 413908
8 XBRL LABEL FILE ppcb-20230630_lab.xml EX-101.LAB 646824
9 XBRL PRESENTATION FILE ppcb-20230630_pre.xml EX-101.PRE 502817
68 EXTRACTED XBRL INSTANCE DOCUMENT forms-1a_htm.xml XML 1896827
Mailing Address 302/6 BUTLER STREET CAMBERWELL, VICTORIA C3 3124
Business Address 302/6 BUTLER STREET CAMBERWELL, VICTORIA C3 3124 61-03-9882-0780
Propanc Biopharma, Inc. (Filer) CIK: 0001517681 (see all company filings)

EIN.: 330662986 | State of Incorp.: DE | Fiscal Year End: 0630
Type: S-1/A | Act: 33 | File No.: 333-273953 | Film No.: 231314985
SIC: 2834 Pharmaceutical Preparations